SCHEDULE 13G/A
Statement of Beneficial Ownership
LB PHARMACEUTICALS INC Filed Acc 0001493152-26-052394
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Trails Edge Capital Partners, LP | 1,149,240 | 3.6% |
| Trails Edge Biotechnology Master Fund, LP | 1,149,240 | 3.6% |
| Ortav Yehudai | 1,149,240 | 3.6% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…